BioCardia, Inc. (BCDA)
Nasdaq: BCDA · Biological Products, (No Diagnostic Substances) · Sunnyvale, CA · filing with the SEC since 1996
Income statement, as filed
In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
| Report filed | Mar 24, 2026 | Mar 26, 2025 | Mar 27, 2024 | Mar 29, 2023 | Mar 29, 2022 | Mar 30, 2021 | Apr 9, 2020 | Apr 2, 2019 | Mar 16, 2018 | Mar 30, 2017 |
| Revenue | 0 | 58 | 477 | 1,352 | 1,015 | 145 | 710 | 625 | 479 | 576 |
| Cost of revenue | · | · | · | · | 0 | 4 | 358 | 517 | 690 | 746 |
| Research and development | 4,962 | 4,387 | 7,726 | 8,834 | 8,558 | 9,809 | 8,562 | 8,453 | 5,799 | 3,330 |
| Selling, general and administrative | 3,316 | 3,672 | 4,395 | 4,419 | 5,087 | 5,861 | 6,003 | 5,757 | 6,395 | 4,108 |
| Total costs and expenses | 8,278 | 8,059 | 12,121 | 13,253 | 13,645 | 15,674 | 14,923 | 14,727 | 12,884 | 8,184 |
| Operating income | -8,278 | -8,001 | -11,644 | -11,901 | -12,630 | -15,529 | -14,213 | -14,102 | -12,405 | -7,608 |
| Interest expense | · | · | · | · | 0 | 3 | 112 | · | 0 | 1,736 |
| Interest and investment income | · | · | · | · | 9 | 21 | · | · | · | · |
| Other income (expense), net | · | · | · | · | -2 | -2 | -2 | -3 | 2 | -2 |
| Total non-operating income (expense) | 50 | 55 | 73 | -6 | 7 | 525 | -496 | 115 | 97 | -2,702 |
| Income tax expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income | -8,228 | -7,946 | -11,571 | -11,907 | -12,623 | -15,004 | -14,709 | -13,987 | -12,308 | -10,310 |
| Earnings per share, basic | -1.23 | -2.90 | -8.19r | -10.05b | -11.25b | · | · | · | · | · |
| Earnings per share, basic and diluted | · | · | · | · | -11.25b | -22.20b | -39.15b | -49.20rb | -43.50rb | -18.45rb |
| Weighted average shares, basic | 6,666,943 | 2,743,828 | 1,411,998r | 1,181,398b | 1,127,844b | · | · | · | · | · |
| Weighted average shares, basic and diluted | · | · | · | · | 1,127,844b | 674,579b | 376,289b | 284,279rb | 282,671rb | 557,886rb |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the 1-for-15 reverse split.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it sold
us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
us-gaap:RevenuesCost of revenue what it cost to make or buy what it sold
us-gaap:CostOfGoodsAndServicesSold
us-gaap:CostOfGoodsSoldResearch and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseSelling, general and administrative the cost of selling and of running the company
us-gaap:SellingGeneralAndAdministrativeExpenseTotal costs and expenses every operating cost, the cost of revenue included
us-gaap:CostsAndExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest expense what its borrowing cost
us-gaap:InterestExpenseInterest and investment income what its cash and investments earned
us-gaap:InvestmentIncomeInterestOther income (expense), net gains and costs outside the business
us-gaap:OtherNonoperatingIncomeExpenseTotal non-operating income (expense) everything outside the business, together
us-gaap:NonoperatingIncomeExpenseIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, basic and diluted net income per share, where both counts are the same
us-gaap:EarningsPerShareBasicAndDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, basic and diluted the average count, where both counts are the same
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted